Table 1 Demographics of the study population
From: The effects of corticosteroids on COPD lung macrophages: a pooled analysis
| Â | Resection Macrophages | Bronchoscopy Macrophages | ||||
|---|---|---|---|---|---|---|
| Â | NS | S | COPD | NS | S | COPD |
n | 14 | 21 | 35 | 6 | 6 | 10 |
GOLD I | NA | NA | 6 | NA | NA | 4 |
GOLD II | NA | NA | 22 | NA | NA | 5 |
GOLD III | NA | NA | 7 | NA | NA | 1 |
Age | 59.6 (15.1) | 69.1 (7.3) | 68.0 (7.3) | 36.0 (8.9) | 43.8 (6.4) | 62.1 (8.4) |
Sex (M/F) | 4/10 | 9/12 | 27/8 | 1/5 | 3/3 | 5/5 |
FEV1 (L) | 2.2 (0.7) | 2.3 (0.8) | 1.9 (0.8) | 3.0 (0.8) | 3.7 (0.9) | 2.0 (0.6) |
FEV1 % Predicted | 99.4 (19.0) | 94.9 (16.6) | 63.6 (18.6) | 101.5 (13.1) | 107.0 (9.0) | 74.4 (21.8) |
FVC (L) | 3.0 (0.9) | 3.0 (0.9) | 3.2 (0.7) | 3.7 (1.2) | 4.8 (1.3) | 3.3 (1.1) |
FEV1/FVC Ratio (%) | 76.3 (6.5) | 75.2 (4.3) | 58.4 (10.5) | 81.0 (6.6) | 76.7 (5.2) | 56.2 (9.9) |
Pack Year History | 0 | 43.2 (23.3) | 54.9 (26.1) | 0 | 15.9 (8.6) | 47.1 (30.2) |
Current/ex-smoker | 0 | 10/11 | 24/11 | 0 | 6 | 7/3 |
ICS Users | 0 | 0 | 13 | 0 | 0 | 7 |